Information  X 
Enter a valid email address

XL TechGroup, Inc. (XLT)


Monday 17 December, 2007

XL TechGroup, Inc.

TyraTech Kraft payment

XL TechGroup, Inc.
17 December 2007

Press Release                                                   17 December 2007

                               XL TechGroup, Inc.
                       ('XL TechGroup' or 'the Company')

                TyraTech receives Kraft Foods milestone payment

XL TechGroup (AIM: XLT), the creator of companies that solve identified, global
unmet market needs, is pleased to advise that XL TechGroup company, TyraTech
Inc. (AIM: TYR) ('TyraTech'), the pioneer of safer, effective and natural
pesticide products, has successfully completed its first stage of development
with Kraft Foods ('Kraft', NYSE: KFT) and received its first milestone payment.

The payment is part of an exclusive worldwide agreement announced last year with
Kraft for the development of compounds used in functional foods and beverages
intended to help prevent human parasitic infection in the developing world.

The first stage of the project provided positive results on the preclinical
efficacy of the TyraTech Natural anti-parasitic compounds in preventing the
development of intestinal parasites.  Following a robust testing protocol, the
team demonstrated TyraTech's unique blend of natural ingredients proved
effective in parasite prevention in a variety of conditions.  Separately,
initial market assessments of parasite prevalence, limitations of current
treatments, consumer awareness and interest in the new solution, combined with
demographic factors indicated strong market potential.

Dr John Scott, CEO of XL TechGroup, said: 'At the time of TyraTech's admission
to AIM earlier this year, a number of specific objectives were targeted for
completion by the end of 2007.  We are delighted that they have all been
delivered, that TyraTech is clearly executing to plan, and we look forward to
further positive news over the coming months.'

                                    - Ends -

For further information:
XL TechGroup Inc.
John Scott / Harold Gubnitsky                               Tel: +1 321 409 7403
[email protected]
Chris Munden, Director of Investor Relations           Tel: +44 (0) 20 7398 7720
[email protected]                                   

Nomura Code Securities
Richard Potts, Corporate Finance                       Tel: +44 (0) 20 7776 1200

XL TechGroup media enquiries:
Abchurch Communications
Heather Salmond / Gareth Mead                          Tel: +44 (0) 20 7398 7700
[email protected]              


About XL TechGroup

XL TechGroup is in the business of significant value creation.  Working with
major international corporate and technology partners such as AES, Procter &
Gamble and leading universities, XL TechGroup first identifies global unmet
market needs and then targets and exploits these by the systematic creation of
successful, disruptive technology businesses.  These new companies are built
from scratch, and are then managed, developed and funded by XL TechGroup through
to the point of a trade sale or a stock market listing.

XL TechGroup's unique and proven methodology selects the best opportunities in
order to create one-to-two new companies annually, where each company is
expected to achieve a realisable valuation of at least US$400 million within
four years from its creation.  It is XL TechGroup's aim to deliver significant
shareholder distributions at the final exit from each company.

XL TechGroup's companies to date are:

• PetroAlgae LLC (

• TyraTech Inc. (AIM: TYR,

• DxTech LLC (

• QuoNova LLC (

• AgCert International plc (LSE: AGC,

XL TechGroup has also established GenXL LLC as a joint venture to capture the
value of those prospects that do not fully meet XL TechGroup's US$400 million,
four year criteria but still demonstrate considerable potential worth.  Over and
above XL TechGroup's core business model, GenXL has announced its first
investments and is reviewing a flow of opportunities from both XL TechGroup and
GEN3 in order to generate new companies, standalone product lines and technology
licensing opportunities or an appropriate mix of these.

For further information, see

About TyraTech, Inc.

TyraTech is pioneering a new class of highly effective, non-toxic, pesticides
and anti-parasitic compounds to address global agriculture, horticulture,
functional foods, healthcare and veterinary markets.  Using a revolutionary
chemoreceptor screening process, TyraTech has identified proprietary blends of
natural oils that stimulate the reactions and biological behaviour of insects
and parasites so that they can be effectively repelled or killed.  TyraTech's
technology prevents the development of resistance and avoids the environmental
concerns and human health risks of chemical solutions whilst still being at
least, if not more, effective.

The Company's products have been validated through strong partnerships with
multinational conglomerates operating within a growing US$23 billion worldwide
market that is being increasingly driven by environmental legislation and
end-user demand.

TyraTech continues to develop new product applications based on safe, natural
ingredients with a broad range of partners around the world.

For further information, see

                      This information is provided by RNS
            The company news service from the London Stock Exchange                                                                                                                                                                                                                                   

a d v e r t i s e m e n t